Beta Bionics, Inc. updated its the quarter ended March 31, 2026 guidance (raised).
“Beta Bionics, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2026.”
Beta Bionics, Inc. — fact timeline
Source-grounded facts extracted from Beta Bionics, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Gerard Michel was appointed as Class III director at Beta Bionics, Inc..
“On March 26, 2025, the Board of Directors (the “Board”) of Beta Bionics, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Gerard Michel as a Class III director of the Company, with a term of office expiring at the 2028 annual meeting of stockholders.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.